Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Besero Pharmaceutical is a specialized pharmaceutical company based in Guangzhou, China, focusing on the research, development, and manufacturing of dermatological and external preparations. Established in 1993, the company has built a strong reputation for its high-quality topical medications, including creams, ointments, and gels. In 2020, the company was acquired by China Resources Sanjiu (CR Sanjiu), a leading Chinese pharmaceutical group, to serve as a core component of its dermatology business unit. Besero's product portfolio features prominent treatments such as Fusidic Acid Cream and Mupirocin Ointment, which are widely used for bacterial skin infections. The company operates state-of-the-art GMP-certified manufacturing facilities and is recognized as a high-tech enterprise in the Guangdong province. Through its integration with CR Sanjiu, Besero continues to expand its market presence and innovation in the field of external drug delivery systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 广州柏赛罗药业.